Breast cancer-associated thrombotic microangiopathy

Breast Care

Volumn 6, Issue 6, 2011, Pages 441-445

  Regierer, Anne C ^a   Kuehnhardt, Dagmar ^a   Schulz, Carsten Oliver ^a   Flath, Bernd ^b   Jehn, Christian F ^a   Scholz, Christian W ^a   Possinger, Kurt ^a   Eucker, Jan ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Hämatologisch onkologische Praxis Altona ^*  (Germany)

Author keywords

ADAMTS13; Bone marrow infiltration; Microangiopathic anemia; Thrombotic hrombocytopenic purpura; Thrombotic microangiopathy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; ARTICLE; BONE MARROW; BREAST CANCER; CANCER INFILTRATION; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEMOLYTIC ANEMIA; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 84455193269     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000335201     Document Type: Article

References (28)

1. Brass L: vWF meets the ADAMTS family. Nat Med 2001;7:1177-1178. (Pubitemid 33063761)
2. Shahab N, Haider S, Doll DC: Vascular toxicity of antineoplastic agents. Semin Oncol 2006;33:121-138. (Pubitemid 43214492)
3. Humphreys BD, Sharman JP, Henderson JM, et al.: Gemcitabine-associated thrombotic microangiopathy. Cancer 2004;100:2664-2670. (Pubitemid 38715773)
4. Chang JC, Naqvi T: Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer. Oncologist 2003;8:375-380. (Pubitemid 36929722)
5. Francis KK, Kalyanam N, Terrell DR, et al.: Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist 2007;12:11-19. (Pubitemid 46143499)
6. Oberic L, Buffet M, Schwarzinger M, et al.: Cancer awareness in atypical thrombotic microangiopathies. Oncologist 2009;14:769-779.
7. Furlan M, Robles R, Galbusera M, et al.: Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-1584. (Pubitemid 28536132)
8. Tsai HM, Lian EC: Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-1594. (Pubitemid 28536133)
9. Fontana S, Gerritsen HE, Kremer Hovinga J, et al.: Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factorcleaving protease. Br J Haematol 2001;113:100-102. (Pubitemid 32423309)
10. Blot E, Decaudin D, Veyradier A, et al.: Cancerrelated thrombotic microangiopathy secondary to von Willebrand factor-cleaving protease deficiency. Thromb Res 2002;106:127-130. (Pubitemid 35245236)
11. Forman RB, Benkel SA, Novik Y, Tsai HM: Presence of ADAMTS13 activity in a patient with metastatic cancer and thrombotic microangiopathy. Acta Haematol 2003;109:150-152. (Pubitemid 36506377)
12. Elliott MA, Letendre L, Gastineau DA, et al.: Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic consideration. Eur J Haematol 2010;85:43-50.
13. Böhm M, Gerlach R, Beecken WD, et al.: ADAMTS-13 activity in patients with brain and prostate tumors is mildly reduced, but not correlated to stage of malignancy and metastasis. Thromb Res 2003;111:33-37. (Pubitemid 37485923)
14. Mannucci PM, Karimi M, Mosalaei A, et al.: Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease). Haematologica 2003;88:454-458. (Pubitemid 36547132)
15. Koo BH, Oh D, Chung SY, et al.: Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients. Thromb Res 2002;105:471-476. (Pubitemid 34686905)
16. Kremer Hovinga JA, Zeerleder S, Kessler P, et al.: ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. J Thromb Haemost 2007;5:2284-2290. (Pubitemid 47617882)
17. Mannucci PM, Vanoli M, Forza I, et al.: Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica 2003;88:914-918. (Pubitemid 37128091)
18. Lin YC, Chang HK, Sun CF, Shih LY: Microangiopathic hemolytic anemia as an initial presentation of metastatic cancer of unknown primary origin. South Med J 1995;88:683-687.
19. Abdel Samie A, Sandritter B, Theilmann L: [Severe microangiopathic hemolytic anemia as first manifestation of a CUP syndrome. Rapid hematologic remission under polychemotherapy]. Med Klin 2004;99:148-153. (Pubitemid 38387678)
20. Von Bubnoff N, Sandherr M, Schneller F, Peschel C: Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast. Am J Clin Oncol 2000;23:74-77. (Pubitemid 30407366)
21. Ataga KI, Graham ML: Microangiopathic hemolytic anemia associated with metastatic breast carcinoma. Am J Hematol 1999;61:254-255. (Pubitemid 29355022)
22. Narita M, Nakao K, Ogino N, et al.: A case of microangiopathic hemolytic anemia associated with breast cancer: improvement with chemoendocrine therapy. Breast Cancer 1997;4:39-42.
23. Nordstrom B, Strang P: Microangiopathic hemolytic anemias (MAHA) in cancer. A case report and review. Anticancer Res 1993;13:1845-1849. (Pubitemid 24008115)
24. Antman KH, Skarin AT, Mayer RJ, et al.: Microangiopathic hemolytic anemia and cancer: a review. Medicine 1979;58:377-384. (Pubitemid 10234880)
25. Lee JL, Lee JH, Kim MK, et al.: A case of bone marrow necrosis with thrombotic thrombocytopenic purpura as a manifestation of occult colon cancer. Jpn J Clin Oncol 2004;34:476-480.
26. Spoormans I, Altintas S, Van den Brande J, et al.: Purpura in a patient with disseminated breast cancer: a rapidly progressive cancer-related thrombotic thrombocytopenic purpura. Ann Oncol 2008;19:1204-1207. (Pubitemid 351796350)
27. Kwaan HC, Gordon LI: Thrombotic microangiopathy in the cancer patient. Acta Haematol 2001;106:52-56. (Pubitemid 32830516)
28. Werner TL, Agarwal N, Carney HM, Rodgers GM: Management of cancer-associated thrombotic microangiopathy: what is the right approach? Am J Hematol 2007;82:295-298. (Pubitemid 46566332)